Earlier Mammography of Breast Cancer Leads to Better Prognosis in 40-49 Year-Olds

Based on a study of nearly 2,000 breast cancer patients, researchers reported that, in women between the ages of 40 and 49, breast tumors identified by mammography have a better prognosis.

The study was published in the March 2012 issue of the journal Radiology. “In our study, women aged 40 to 49 whose breast cancer was detected by mammography were easier to treat and had less recurring disease and mortality, because their cancer was found at an earlier stage,” said Judith A. Malmgren, PhD, president of HealthStat Consulting, Inc. (Seattle, WA, USA).

Dr. Malmgren and a team of researchers reviewed breast cancer-patient data from a dedicated registry at the Swedish Cancer Institute’s (Seattle, WA, USA) community cancer center. The researchers analyzed data on 1,977 breast cancer patients between the ages of 40 and 49 who were treated between 1990 and 2008. The researchers looked at method of diagnosis (detected by mammography, patient, or physician), stage at diagnosis (0-IV, confirmed by biopsy), treatment, and annual follow-up data, including recurrence of disease.

“Our goal was to assess the differences between mammography and non-mammography detected breast cancer, to determine whether earlier detection confers a treatment and morbidity advantage because the disease is found at an earlier stage,” Dr. Malmgren said.

The data analysis revealed a substantial increase in the percentage of mammography-detected breast cancer over the 18-year period: from 28% in 1990 to 58% in 2008. Over the same period, patient- and physician-detected breast cancer declined from 73% of all cases in 1990 to 42% in 2008. “The shift toward more mammography-detected breast cancer cases was accompanied by a shift toward diagnosis at an earlier stage of disease that required less treatment,” Dr. Malmgren said.

Over the 18-year period, the number of breast cancers detected at stage 0 increased by 66%, while the number of stage III breast cancers decreased by 66%. Most of stage 0 cancer instances were ductal carcinoma in situ (DCIS), a noninvasive cancer that is confined to a milk duct. The treatment of DCIS remains controversial, because not all experts agree that it is potentially life threatening.

Dr. Malmgren reported that another major finding of the study was the extent of treatment patients received. Compared with women whose cancer was self-detected or discovered by a physician, patients whose cancer was detected using mammography were more likely to have breast-conserving treatment and less likely to have chemotherapy. Specifically, they were more likely to undergo lumpectomy (67% versus 48%), less likely to undergo modified radical mastectomy (25% versus 47%), and less likely to die of breast cancer (4% versus 11%).

“The benefits of breast cancer treatment are accompanied by significant harms,” Dr. Malmgren said. “Chemotherapy may have long-lasting toxic effects on a woman’s body, and mastectomy and reconstructive surgery are difficult and expensive operations that can have a significant effect on body image.”

The American Cancer Society (Houston, TX, USA) and other medical organizations recommend that women should begin receiving annual mammograms to screen for breast cancer beginning at age 40. In 2009, the US Preventive Services Task Force issued controversial new guidelines that eliminated the longstanding recommendation for routine mammography screening for women between the ages of 40 and 49, stating that the benefits of screening were possibly outweighed by the harms of screening, such as false-positive findings.

“The objective of screening is to detect disease at an earlier, more treatable stage, which--based on our review--mammography accomplishes,” Dr. Malmgren concluded.

Related Links:
HealthStat Consulting
Swedish Cancer Institute